When ACR or CAR was expressed in effector T cells, it activated T cells effectively by costimulating CD28 and CD137 (4-1BB) upon engagement of PD-L1+ tumor cells (Figure 1C). The gene discussed is TNFRSF9; the disease is neoplasm.